The China API market is estimated to witness a growth rate of around 7.5% during the forecast period. China was the largest exporter of API globally with exporting volume of over 500 million tons in 2018. Well-developed infrastructure, large production capability, high prevalence of the chronic disease in the country such as cancer, CVD and so on are some of the factors that are responsible for the strong market growth in the country. China is the largest API supplier across the globe due to the increased focus on the pharmaceutical manufacturing sector coupled with the low production cost in the country. 

Visit for Global API Market Report at: https://www.omrglobal.com/industry-reports/api-market

The China API market is segmented on the basis of type, type of synthesis, manufacturer type, therapeutics, and region. On the basis of type, the market is divided into a generic API and branded API. The branded API segment is estimated to be the dominant segment over the forecast period. On the basis of the type of synthesis, the market is classified into biotech API, synthetic API, and others. The synthetic API segment held the dominant position in the country’s API market in 2018. Furthermore, the market is classified on the basis of therapeutics into cardiovascular drugs, oncology drugs, neurology drugs, Non-steroidal Anti-inflammatory Drugs (NSAIDs), and others. 

Some of the prominent players that contribute significantly in the China API market include Teva Pharmaceutical Industries Ltd., Piramal Enterprises Ltd., Sun Pharmaceutical Industries Ltd., Aurobindo Pharma, Novartis International AG, Boehringer Ingelheim International GmbH, and others. These players operate in very highly competitive environment and thus adopts various strategies to stay competitive in the market. Mergers and acquisitions, new product launch, geographical expansion, manufacturing capability expansion are some of the majorly adopted strategies by these market players.

Research Methodology

The market study of the China API market is incorporated by extensive primary and secondary research conducted by the research team at OMR.  Secondary research has been conducted to refine the available data to breakdown the market in various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior and macro-economic factors. Numbers extracted from Secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives, managers, key opinion leaders, and industry experts. Primary research brings authenticity to our reports.

Secondary Sources Include

• Financial reports of companies involved in the market.
• Authenticate databases such as the American Heart Association, the National Institute of Health, and the International Diabetes Federation.
• Whitepapers, research-papers, and news blogs.
• Company websites and their product catalog.

The report is intended for pharmaceutical and biotechnology companies, healthcare organizations, research institutes and academic institutes, pharmaceutical drug manufacturers, API manufacturers, raw material suppliers, distributors, traders, government organizations and regulatory agencies, and other market participants for overall market analysis and competitive analysis. The report provides an in-depth analysis of market size, different products, and future market opportunities. The report will serve as a source for a 360-degree analysis of the market thoroughly delivering insights into the market for making better business decisions.

Market Segmentation

1. China API Market Research and Analysis by Type
2. China API Market Research and Analysis by Type of Synthesis
3. China API Market Research and Analysis by Therapeutics

The Report Covers

• Comprehensive research methodology of China API market.
• This report also includes a detailed and extensive market overview with key analyst insights.
• An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
• Analysis of regional regulations and other government policies impacting China API market.
• Insights about market determinants that are stimulating China API market.
• Detailed and extensive market segments with regional distribution of forecasted revenues.
• Extensive profiles and recent developments of market players.